Asia Pacific Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

About the Report

About the Report

Asia Pacific digital respiratory solutions market will grow by 41.6% annually with a total addressable market cap of USD 219.0 million over 2020-2030 owing to the rising demand for respiratory aids and air purification amid COVID-19 pandemic.

Highlighted with 31 tables and 42 figures, this 104-page report Asia Pacific Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Asia Pacific digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country.

Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Therapeutic Devices

Inhalers

Nebulizers

Diagnostic Devices

Spirometers

Asthma Monitors

Other Diagnostic Devices

Sensors and Apps

Based on Indication, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

COVID-19 Caused Diseases

Other Diseases

Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Geographically, the following national/local markets are fully investigated:

Japan

China

South Korea

Australia

India

Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)

For each aforementioned country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in Asia Pacific digital respiratory solutions market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

3M Health Care Limited

Adherium Limited

Amiko Digital Health Limited

AsthmaMD

AstraZeneca plc

Boehringer Ingelheim International GmbH

Capsule Technologies, Inc.

Cohero Health

GlaxoSmithKline plc

Kaia Health Software GmbH

Medical International Research (MIR)

Novartis AG

NuvoAir

Reciprocal Labs (Propeller Health)

Sensiron AG

Tactio Health

Teva Pharmaceuticals Industries Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Products


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

3M Health Care Limited

Adherium Limited

Amiko Digital Health Limited

AsthmaMD

AstraZeneca plc

Boehringer Ingelheim International GmbH

Capsule Technologies, Inc.

Cohero Health

GlaxoSmithKline plc

Kaia Health Software GmbH

Medical International Research (MIR)

Novartis AG

NuvoAir

Reciprocal Labs (Propeller Health)

Sensiron AG

Tactio Health

Teva Pharmaceuticals Industries Ltd.

Table Of Content

Table Of Content

1 Introduction 5

1.1 Industry Definition and Research Scope 5

1.1.1 Industry Definition 5

1.1.2 Research Scope 6

1.2 Research Methodology 9

1.2.1 Overview of Market Research Methodology 9

1.2.2 Market Assumption 10

1.2.3 Secondary Data 10

1.2.4 Primary Data 10

1.2.5 Data Filtration and Model Design 12

1.2.6 Market Size/Share Estimation 13

1.2.7 Research Limitations 14

1.3 Executive Summary 15

2 Market Overview and Dynamics 17

2.1 Market Size and Forecast 17

2.1.1 Impact of COVID-19 on the Market 18

2.2 Major Growth Drivers 20

2.3 Market Restraints and Challenges 25

2.4 Emerging Opportunities and Market Trends 28

2.5 Porter's Fiver Forces Analysis 32

3 Segmentation of Asia Pacific Market by Product Type 37

3.1 Market Overview by Product Type 37

3.2 Therapeutic Devices 39

3.2.1 Inhalers 40

3.2.2 Nebulizers 41

3.3 Diagnostic Devices 42

3.3.1 Spirometers 44

3.3.2 Asthma Monitors 45

3.3.3 Other Diagnostic Devices 46

3.4 Sensors and Apps 47

4 Segmentation of Asia Pacific Market by Indication 48

4.1 Market Overview by Indication 48

4.2 Asthma 50

4.3 Chronic Obstructive Pulmonary Disease (COPD) 51

4.4 COVID-19 Caused Diseases 52

4.5 Other Diseases 53

5 Segmentation of Asia Pacific Market by Distribution Channel 54

5.1 Market Overview by Distribution Channel 54

5.2 Hospital Pharmacies 56

5.3 Retail Pharmacies 57

5.4 Online Pharmacies 58

6 Asia-Pacific Market 2019-2030 by Country 59

6.1 Overview of Asia-Pacific Market 59

6.2 Japan 62

6.3 China 65

6.4 Australia 68

6.5 India 70

6.6 South Korea 72

6.7 Rest of APAC Region 74

7 Competitive Landscape 76

7.1 Overview of Key Vendors 76

7.2 New Product Launch, Partnership, Investment, and M&A 79

7.3 Company Profiles 80

3M Health Care Limited 80

Adherium Limited 82

Amiko Digital Health Limited 83

AsthmaMD 84

AstraZeneca plc 85

Boehringer Ingelheim International GmbH 86

Capsule Technologies, Inc. 87

Cohero Health 88

GlaxoSmithKline plc 89

Kaia Health Software GmbH 90

Medical International Research (MIR) 91

Novartis AG 92

NuvoAir 93

Reciprocal Labs (Propeller Health) 94

Sensiron AG 95

Tactio Health 96

Teva Pharmaceuticals Industries Ltd. 97

8 Investing in Asia Pacific Market: Risk Assessment and Management 98

8.1 Risk Evaluation of Asia Pacific Market 98

8.2 Critical Success Factors (CSFs) 101

Related Reports and Products 104


List Of Figure

Figure 1. Research Method Flow Chart 9

Figure 2. Breakdown of Primary Research 11

Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 13

Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 15

Figure 5. Asia Pacific Digital Respiratory Solutions Market, 2019-2030, USD mn 17

Figure 6. Primary Drivers and Impact Factors of Asia Pacific Digital Respiratory Solutions Market 20

Figure 7. GDP per capita in the World, 1960-2018, USD thousand 23

Figure 8. Forecast of Middle-class Population by Region, 2015-2030, million 23

Figure 9. Worldwide Connected Devices by Device Type, 2014-2022, billion units 24

Figure 10. Primary Restraints and Impact Factors of Asia Pacific Digital Respiratory Solutions Market 25

Figure 11. Investment Opportunity Analysis 29

Figure 12. Porter's Fiver Forces Analysis of Asia Pacific Digital Respiratory Solutions Market 32

Figure 13. Breakdown of Asia Pacific Digital Respiratory Solutions Market by Product Type, 2019-2030, % of Sales Revenue 37

Figure 14. Asia Pacific Addressable Market Cap in 2020-2030 by Product Type, Value (USD mn) and Share (%) 38

Figure 15. Asia Pacific Digital Respiratory Solutions Market: Therapeutic Devices, 2019-2030, USD mn 39

Figure 16. Asia Pacific Digital Respiratory Solutions Market: Inhalers, 2019-2030, USD mn 40

Figure 17. Asia Pacific Digital Respiratory Solutions Market: Nebulizers, 2019-2030, USD mn 41

Figure 18. Asia Pacific Digital Respiratory Solutions Market: Diagnostic Devices, 2019-2030, USD mn 42

Figure 19. Asia Pacific Digital Respiratory Solutions Market: Spirometers, 2019-2030, USD mn 44

Figure 20. Asia Pacific Digital Respiratory Solutions Market: Asthma Monitors, 2019-2030, USD mn 45

Figure 21. Asia Pacific Digital Respiratory Solutions Market: Other Diagnostic Devices, 2019-2030, USD mn 46

Figure 22. Asia Pacific Digital Respiratory Solutions Market: Sensors and Apps, 2019-2030, USD mn 47

Figure 23. Breakdown of Asia Pacific Digital Respiratory Solutions Market by Indication, 2019-2030, % of Sales Revenue 49

Figure 24. Asia Pacific Addressable Market Cap in 2020-2030 by Indication, Value (USD mn) and Share (%) 49

Figure 25. Asia Pacific Digital Respiratory Solutions Market: Asthma, 2019-2030, USD mn 50

Figure 26. Asia Pacific Digital Respiratory Solutions Market: Chronic Obstructive Pulmonary Disease (COPD), 2019-2030, USD mn 51

Figure 27. Asia Pacific Digital Respiratory Solutions Market: COVID-19 Caused Diseases, 2019-2030, USD mn 52

Figure 28. Asia Pacific Digital Respiratory Solutions Market: Other Diseases, 2019-2030, USD mn 53

Figure 29. Breakdown of Asia Pacific Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, % of Revenue 55

Figure 30. Asia Pacific Addressable Market Cap in 2020-2030 by Distribution Channel, Value (USD mn) and Share (%) 55

Figure 31. Asia Pacific Digital Respiratory Solutions Market: Hospital Pharmacies, 2019-2030, USD mn 56

Figure 32. Asia Pacific Digital Respiratory Solutions Market: Retail Pharmacies, 2019-2030, USD mn 57

Figure 33. Asia Pacific Digital Respiratory Solutions Market: Online Pharmacies, 2019-2030, USD mn 58

Figure 34. Breakdown of APAC Digital Respiratory Solutions Market by Country, 2019 and 2030, % of Revenue 60

Figure 35. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value (USD mn) and Share (%) 61

Figure 36. Digital Respiratory Solutions Market in Japan, 2019-2030, USD mn 63

Figure 37. Digital Respiratory Solutions Market in China, 2019-2030, USD mn 66

Figure 38. Digital Respiratory Solutions Market in Australia, 2019-2030, USD mn 68

Figure 39. Digital Respiratory Solutions Market in India, 2019-2030, USD mn 70

Figure 40. Digital Respiratory Solutions Market in South Korea, 2019-2030, USD mn 72

Figure 41. Digital Respiratory Solutions Market in Rest of APAC, 2019-2030, USD mn 74

Figure 42. Growth Stage of Asia Pacific Digital Respiratory Solutions Industry over the Forecast Period 76


List Of Table

Table 1. Snapshot of Asia Pacific Digital Respiratory Solutions Market, 2019-2030 16

Table 2. Main Product Trends and Market Opportunities in Asia Pacific Digital Respiratory Solutions Market 28

Table 3. Asia Pacific Digital Respiratory Solutions Market by Product Type, 2019-2030, USD mn 37

Table 4. Asia Pacific Digital Respiratory Solutions Market: Therapeutic Devices by Type, 2019-2030, USD mn 39

Table 5. Asia Pacific Digital Respiratory Solutions Market: Diagnostic Devices by Type, 2019-2030, USD mn 43

Table 6. Asia Pacific Digital Respiratory Solutions Market by Indication, 2019-2030, USD mn 48

Table 7. Asia Pacific Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, USD mn 54

Table 8. APAC Digital Respiratory Solutions Market by Country, 2019-2030, USD mn 60

Table 9. Japan Digital Respiratory Solutions Market by Product Type, 2019-2030, USD mn 64

Table 10. Japan Digital Respiratory Solutions Market by Indication, 2019-2030, USD mn 64

Table 11. Japan Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, USD mn 64

Table 12. China Digital Respiratory Solutions Market by Product Type, 2019-2030, USD mn 67

Table 13. China Digital Respiratory Solutions Market by Indication, 2019-2030, USD mn 67

Table 14. China Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, USD mn 67

Table 15. Australia Digital Respiratory Solutions Market by Product Type, 2019-2030, USD mn 69

Table 16. Australia Digital Respiratory Solutions Market by Indication, 2019-2030, USD mn 69

Table 17. Australia Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, USD mn 69

Table 18. India Digital Respiratory Solutions Market by Product Type, 2019-2030, USD mn 71

Table 19. India Digital Respiratory Solutions Market by Indication, 2019-2030, USD mn 71

Table 20. India Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, USD mn 71

Table 21. South Korea Digital Respiratory Solutions Market by Product Type, 2019-2030, USD mn 73

Table 22. South Korea Digital Respiratory Solutions Market by Indication, 2019-2030, USD mn 73

Table 23. South Korea Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, USD mn 73

Table 24. Digital Respiratory Solutions Market in Rest of APAC by Country, 2019-2030, USD mn 75

Table 25. 3M Health Care Limited: Company Snapshot 80

Table 26. 3M Health Care Limited: Business Segmentation 80

Table 27. 3M Health Care Limited: Product Portfolio 81

Table 28. 3M Health Care Limited: Revenue, 2016-2018, USD mn 81

Table 29. 3M Health Care Limited: Recent Developments 81

Table 30. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030 99

Table 31. Critical Success Factors and Key Takeaways 102

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

408564 Reports in repository
150+ Consulting project
100+ Analysts
8000+ Client Queries in 2022